OSE Immunotherapeutics SA (EPA: OSE)

OSE Immunotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	154	81	123	188	129	55
Market Cap Growth	95.13%	-34.73%	-34.26%	45.49%	133.63%	9.99%
Enterprise Value	122	109	128	184	126	36
Last Close Price	7.06	4.28	6.67	10.28	7.20	3.70
PE Ratio	3.51	-	-	-	-	-
Forward PE	2.25	-	-	-	-	-
PS Ratio	1.79	36.17	6.74	7.14	12.38	2.13
PB Ratio	1.89	3.51	3.78	3.92	2.10	0.94
P/TBV Ratio	1.46	3.53	3.80	3.93	2.10	0.94
P/FCF Ratio	2.63	-	-	-	-	6.28
P/OCF Ratio	2.04	-	-	-	-	6.05
EV/Sales Ratio	1.46	49.07	6.99	7.01	12.09	1.38
EV/EBITDA Ratio	2.27	-	-	-	-	-
EV/EBIT Ratio	2.26	-	-	-	-	-
EV/FCF Ratio	2.09	-	-	-	-	4.06
Debt / Equity Ratio	0.54	1.99	1.37	0.78	0.32	0.20
Debt / EBITDA Ratio	0.82	-	-	-	-	-
Debt / FCF Ratio	0.75	-	-	-	-	1.30
Asset Turnover	0.75	0.03	0.19	0.26	0.11	0.31
Quick Ratio	4.70	1.40	1.97	2.36	2.57	2.11
Current Ratio	4.93	1.62	2.29	2.64	2.82	2.31
Return on Equity (ROE)	88.54%	-82.70%	-44.10%	-30.85%	-27.61%	-7.73%
Return on Assets (ROA)	30.41%	-16.53%	-11.93%	-10.45%	-12.77%	-1.11%
Return on Capital (ROIC)	35.12%	-19.65%	-14.22%	-12.53%	-15.73%	-1.35%
Earnings Yield	28.53%	-28.56%	-14.39%	-8.98%	-12.83%	-8.42%
FCF Yield	37.98%	-24.56%	-15.01%	-5.54%	-15.32%	15.93%
Buyback Yield / Dilution	-22.97%	-5.58%	-2.05%	-16.71%	-4.46%	4.03%
Total Shareholder Return	-22.97%	-5.58%	-2.05%	-16.71%	-4.46%	4.03%

Source: S&P Capital IQ. Standard template. Financial Sources.